Company news

Advicenne SA news in 2025

Advicenne SA's news releases, calls and decks from 2025, newest first.

View company

Advicenne Has Submitted to US FDA the Registration Application for Sibnayal® in dRTA Treatment

November 4, 2025

Advicenne Reports First Half Financial Results as of June 30, 2025, and Updates on Its Activities

September 19, 2025

Advicenne Announces the Publication in Orphanet Journal of Rare Diseases of the Long-term European Study Results of dRTA Treatment Using ADV7103

August 26, 2025

Advicenne Receives Marketing Authorization and Reimbursement for Sibnayal® in Saudi Arabia

July 28, 2025

Advicenne Reports its H1 2025 Sales

July 25, 2025

Advicenne Raises 2.6 Million Euros in Its Capital Increase and Extends Its Financial Visibility

July 21, 2025

Advicenne 2024 Universal Registration Document Made Available

April 29, 2025

Decks in 2025